Adaptive Servoventilation in Patients with Central or Complex Sleep Apnea Related to Chronic Opioid Use and Congestive Heart Failure

摘要

Adaptive servoventilation (ASV) is often used to treat central sleep apnea (CSA) and complex sleep apnea syndrome (CompSAS). Both CompSAS and CSA may occur in the setting of CHF and with the use of chronic opioids. We hypothesized that ASV would be less successful in treatment of CSA and CompSAS secondary to opioid use than in CHF patients.